MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Pursuant to SEBI Circular No. SEBI/HO/ISD/CIR/P/2020/135 dated July 23, 2020, enclosed herewith kindly find reporting of violations related to Code of Conduct under SEBI (PIT) Regulations, 2015 by one Designated Person of the Company in the prescribed formats. MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in compliance with General Circular No.20/2020 dated May 5, 2020 issued by the Ministry of Corporate Affairs, we enclose herewith extract of newspaper advertisement published in Business Standard (English) and Tarun Bharat (Marathi) newspapers intimating, inter alia, 28th Annual General Meeting to be held on Tuesday, 29th September, 2020 at 11:00 a.m. through VC/ OAVM facility. MARKSANS PHARMA LTD. - 524404 - Outcome Of Board Meeting
Please be informed that the Board of Directors at its meeting held on 4th August, 2020 has, subject to approval of the shareholders at the ensuing Annual General Meeting, re-appointed Mr. Mark Saldanha (DIN: 00020983) as Managing Director of the Company for a period of five (5) years with effect from 6th October, 2020. Further, the Board of Directors at its meeting held on 4th August, 2020 has, subject to approval of the shareholders at the ensuing Annual General Meeting, re-appointed Mrs. Sandra Saldanha (DIN: 00021023) as Whole-time Director of the Company for a period of three (3) years with effect from 25th September, 2020. MARKSANS PHARMA LTD. - 524404 - Notice Of Book Closure Dates
We wish to inform you that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2020 to September 29, 2020 (both days inclusive) for the purpose of Annual General Meeting to be held on September 29, 2020 and Payment of Dividend,if declared at the Annual General Meeting. MARKSANS PHARMA LTD. - 524404 - Intimation Of 28Th Annual General Meeting
We wish to inform you that the 28th Annual General Meeting ('AGM') of the Members of Marksans Pharma Limited ('the Company') is scheduled to be held on Tuesday, 29th September, 2020 at 11:00 a.m. through Video Conferencing /Other Audio Visual Means (VC/OAVM) facility in accordance with the procedure prescribed in circular no. 20/2020 dated May 05, 2020 read with circular no. 14/2020 dated April 08, 2020 and circular no. 17/2020 dated April 13, 2020 issued by the Ministry of Corporate Affairs and circular no. SEBI/HO/CFD/CMD1/CIR/P/2020/79 dated May 12, 2020 issued by the Securities and Exchange Board of India. The Annual Report for 2019-20, including the AGM Notice which contains the process and manner of attending the Annual General Meeting through VC/ OAVM and e-voting and other details, will be sent through electronic mode to the Members of the Company as well as to the Exchange in due course. MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investor Meeting MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached an investors presentation of Marksans Pharma Limited for Q1 FY21. MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Enclosed herewith kindly find a News Release dated 4th August, 2020 of the Company. MARKSANS PHARMA LTD. - 524404 - Unaudited Financial Results For The Quarter Ended 30Th June, 2020 And Limited Review Reports Thereon.
In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results for the quarter ended 30th June, 2020 (both Standalone and Consolidated) approved by the Board of Directors at its meeting held today i.e. 4th August, 2020 along with Limited Review Reports thereon. The meeting commenced at 10:15 a.m. and concluded at 11:15 a.m. In this connection, we hereby certify that the Auditors have given their reports on the Unaudited Financial Results for the quarter ended 30th June, 2020 (both Standalone and Consolidated) with unmodified opinion. MARKSANS PHARMA LTD. - 524404 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read alongwith SEBI Circular CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please find enclosed herewith the Annual Secretarial Compliance Report of the Company for the financial year 2019-20 issued by Mr. Jinesh Dedhia of Jinesh Dedhia & Associates, Practicing Company Secretaries.